The American Academy of Pain Medicine      Annual Meeting Home Page     
24th Annual Meeting February 13-18, 2008 Orlando, FL
Annual Meeting Highlights
Supported by an educational grant from Merck & Co., Inc.



© 2006 American Academy of Pain Medicine
Friday, February 15, 2008: 4:15 PM-5:30 PM
(304) Neuromodulation Consensus Guidelines: Electrical Stimulation and Intrathecal Therapies
Utilization of neuromodulation therapies, specifically intrathecal drug delivery (IDD) and spinal cord stimulation (SCS), has significantly increased over the past several years. Historically, neuromodulation therapies were considered only after years of failed conventional therapies. However, technological advances and novel analgesic compounds have enhanced the safety, reliability, and efficacy of neuromodulation therapies, thus providing a rationale for earlier use in the treatment of refractory pain conditions. Expert panels of physicians and nonphysicians were recently convened to update previous recommendations and form consensus guidelines for the rational use of IDD and SCS. These panels reviewed existing data and formulated suggested algorithms for the use of neuromodulation therapies based on best evidence and expert opinion. This symposium will review the consensus guidelines developed by the expert panels and will examine economic considerations as they relate to access to care for neuromodulation therapies.
4:15 PM Introduction
Timothy Deer, MD
4:20 PM Spinal Cord Stimulation Current best evidence
Timothy Deer, MD
4:40 PM Intrathecal Drug Therapy Current Best Evidence
Lynn R. Webster, MD FACPM
5:00 PM Cost-Effectiveness of Spinal Cord Stimulation and Intrathecal Drug Therapies: Justifying the Costs of Neuromodulation
B. Todd Sitzman, MD MPH
5:15 PM Question & Answer

See more of Scientific Sessions

See more of The 24th Annual Meeting